Related Experiment Videos
Bcl-2 and Bcl-X expression in gangliogliomas
1Department of Pathology, Cleveland Clinic Foundation, OH 44195, USA.
Human Pathology
|June 22, 1999
Summary
Bcl-2 protein expression was frequent in gangliogliomas, unlike Bcl-xL. These findings suggest apoptosis abnormalities may contribute to ganglioglioma development.
Area of Science:
- Neuro-oncology
- Molecular biology
- Cellular pathology
Background:
- Gangliogliomas are rare tumors with both neuronal and glial components.
- The role of apoptosis-regulating proteins, such as Bcl-2 and Bcl-xL, in ganglioglioma pathogenesis is not well understood.
Purpose of the Study:
- To investigate the expression patterns of Bcl-2 and Bcl-xL proteins in a cohort of gangliogliomas.
- To correlate protein expression with tumor characteristics and cell proliferation markers.
Main Methods:
- Retrospective analysis of 29 ganglioglioma tissue samples using immunohistochemistry.
- Evaluation of Bcl-2 and Bcl-xL protein expression in neuronal and glial components.
- Assessment of MIB-1 labeling index as a measure of cell proliferation.
Main Results:
- Bcl-2 expression was detected in 86% of tumors, predominantly in the neuronal component (83%).
- Bcl-xL expression was less frequent, observed in 28% of tumors, mainly in neurons.
- No significant correlation was found between MIB-1 labeling index and Bcl-2 or Bcl-xL expression.
Conclusions:
- Bcl-2 is frequently expressed in gangliogliomas, while Bcl-xL expression is less common.
- The differential expression of these apoptosis regulators may indicate their involvement in ganglioglioma cell survival and tumor development.